Literature DB >> 5415412

Quantitative determination of 1-alkylindoles in cigarette smoke.

D Hoffmann, G Rathkamp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5415412     DOI： 10.1021/ac60285a023

Source DB:  PubMed          Journal:  Anal Chem        ISSN： 0003-2700            Impact factor:   6.986


× No keyword cloud information.
  7 in total

Review 1.  Lung surfactant and pulmonary toxicology.

Authors:  H P Haagsman; L M van Golde
Journal:  Lung       Date:  1985       Impact factor: 2.584

2.  3-Methylindole metabolites induce lung CYP1A1 and CYP2F1 enzymes by AhR and non-AhR mechanisms, respectively.

Authors:  Jessica M Weems; Garold S Yost
Journal:  Chem Res Toxicol       Date:  2010-03-15       Impact factor: 3.739

3.  3-methylindole-induced pulmonary injury in goats.

Authors:  T W Huang; J R Carlson; T M Bray; B J Bradley
Journal:  Am J Pathol       Date:  1977-06       Impact factor: 4.307

4.  The pneumotoxin 3-methylindole is a substrate and a mechanism-based inactivator of CYP2A13, a human cytochrome P450 enzyme preferentially expressed in the respiratory tract.

Authors:  Jaime D'Agostino; Xiaoliang Zhuo; Mohammad Shadid; Daniel G Morgan; Xiuling Zhang; W Griffith Humphreys; Yue-Zhong Shu; Garold S Yost; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2009-07-16       Impact factor: 3.922

5.  The effect of 3-methylindole on the uptake and incorporation of 14C-choline into phospholipids in lung tissue slices.

Authors:  J B Kirkland; T M Bray
Journal:  Lipids       Date:  1984-10       Impact factor: 1.880

Review 6.  The epidermis and the respiratory tract as bioassay systems in tobacco carcinogenesis.

Authors:  E L Wynder; D Hoffmann
Journal:  Br J Cancer       Date:  1970-09       Impact factor: 7.640

7.  Skatole (3-Methylindole) Is a Partial Aryl Hydrocarbon Receptor Agonist and Induces CYP1A1/2 and CYP1B1 Expression in Primary Human Hepatocytes.

Authors:  Martin Krøyer Rasmussen; Patrick Balaguer; Bo Ekstrand; Martine Daujat-Chavanieu; Sabine Gerbal-Chaloin
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.